Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)
24 mars 2021 11h34 HE
|
Tauriga Sciences
Commercial Launch of Tauri-Pet™ Product Line is Anticipated: April 20, 2021 NEW YORK, NY, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or...
Tauriga Sciences Inc. Files International Patent Application, Relating to its Proposed Pharmaceutical Cannabinoid Chewing Gum, Under the Patent Cooperation Treaty
22 mars 2021 08h10 HE
|
Tauriga Sciences
NEW YORK, NY, March 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with...
Tauriga Sciences, Inc. Converts its U.S. Provisional Patent Application (Filed on March 17, 2020) to a U.S. Non-Provisional Patent Application
22 mars 2021 06h18 HE
|
Tauriga Sciences
To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW...
Tauriga Sciences Inc. Enters into 6 Month Agreement with Coalition Technologies to Enhance its Search Engine Optimization Metrics
19 mars 2021 10h26 HE
|
Tauriga Sciences
The Company is Focused on Both Increasing Tauri-Gum™ Brand Awareness and E-Commerce Revenue NEW YORK, NY, March 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)...
Tauriga Sciences Inc. Commences Development of Delta-8-THC Infused Version of Tauri-Gum
17 mars 2021 09h03 HE
|
Tauriga Sciences
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with...
Tauriga Sciences Inc. Assembles Territorial On-the-Ground Sales Force, Initially Focused on Seven U.S. Cities
15 mars 2021 11h57 HE
|
Tauriga Sciences
The Company’s Assembling of this Sales Force Coincides with Launch of its Increased Tauri-Gum™ CBD & CBG Infusion Concentrations (25mg/per Serving) NEW YORK, NY, March 15, 2021 (GLOBE NEWSWIRE)...
Tauriga Sciences Inc. Completely Free of Convertible Debt
15 mars 2021 08h53 HE
|
Tauriga Sciences
The Company Has Fully Repaid and Retired Its Final Outstanding Convertible Debenture NEW YORK, NY, March 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)...
Tauriga Sciences Inc. Completes Payment for the Entirety of its Recently Announced - Largest Tauri-Gum Production Run in Company History
09 mars 2021 11h05 HE
|
Tauriga Sciences
This Production Run Incorporates the Increased CBD & CBG Infusion Concentrations (25mg per Each Piece of Chewing Gum) NEW YORK, NY, March 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --...
Tauriga Sciences Inc. Selects First Foods Group, Inc. to Manufacture its New, Full Spectrum CBD Infused Product Line
05 mars 2021 07h18 HE
|
Tauriga Sciences
This Full Spectrum CBD Infused Product Line contains 25mg per Serving (“Bite”) / 600mg per Jar (“Unit”) NEW YORK, NY, March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences,...
Tauriga Sciences Inc. Acquires Equity Stake in Israeli Biotechnology Firm that Develops Drugs Based on Cannabinoid Molecules
01 mars 2021 10h56 HE
|
Tauriga Sciences
NEW YORK, NY, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with...